Finance

Lists
PPLPHARMA:NSE
Piramal Pharma Ltd (Mumbai)
211,50 INR
-0,47%
(-0,99) 1D
11 სექ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for PPLPHARMA...
Open
210,59 INR
High
214,45 INR
Low
208,68 INR
Mkt. cap
279,85 მლრ.
Avg. vol.
0,00
Volume
3,41 მლნ.
52-wk high
231,93 INR
52-wk low
132,30 INR
EPS
-2,37 INR
No. of employees
7 ათ.
Open
210,59 INR
High
214,45 INR
Low
208,68 INR
Mkt. cap
279,85 მლრ.
Avg. vol.
0,00
Volume
3,41 მლნ.
52-wk high
231,93 INR
52-wk low
132,30 INR
EPS
-2,37 INR
No. of employees
7 ათ.
About Piramal Pharma Ltd (Mumbai)
CEOპიტერ დეიონგ
Employees7,12 ათ.
Founded2020
Headquarters-
SectorPharmaceutical industry
Websitepiramalpharma.com
Last report
30 ივლ. 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
-0,52 INR / -0,61 INR
+15,03%beat
Revenue / Est. (INR)
22,70 მლრდ. / 21,49 მლრდ.
+5,63%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
20,44 მლრდ.
21,40 მლრდ.
27,52 მლრდ.
22,70 მლრდ.
Cost of goods sold
7,02 მლრდ.
7,86 მლრდ.
13,95 მლრდ.
8,52 მლრდ.
Cost of revenue
7,02 მლრდ.
7,86 მლრდ.
13,95 მლრდ.
8,52 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,11 მლრდ.
6,00 მლრდ.
8,19 მლრდ.
6,76 მლრდ.
Operating expense
13,85 მლრდ.
13,71 მლრდ.
11,09 მლრდ.
14,46 მლრდ.
Total operating expenses
20,88 მლრდ.
21,57 მლრდ.
25,04 მლრდ.
22,98 მლრდ.
Operating income
-441,50 მლნ.
-170,10 მლნ.
2,47 მლრდ.
-283,50 მლნ.
Other non operating income
656,00 მლნ.
432,40 მლნ.
-977,90 მლნ.
894,10 მლნ.
EBT including unusual items
-461,80 მლნ.
-938,60 მლნ.
430,00 მლნ.
-74,60 მლნ.
EBT excluding unusual items
-461,80 მლნ.
-527,50 მლნ.
1,40 მლრდ.
-74,60 მლნ.
Income tax expense
530,40 მლნ.
423,30 მლნ.
518,30 მლნ.
619,30 მლნ.
Effective tax rate
-114,85%
-45,10%
120,53%
-830,16%
Other operating expenses
5,71 მლრდ.
5,58 მლრდ.
723,30 მლნ.
5,47 მლრდ.
Net income
-992,20 მლნ.
-1,36 მლრდ.
-88,30 მლნ.
-693,90 მლნ.
Net profit margin
-4,85%
-6,36%
-0,32%
-3,06%
Earnings per share
-0,75
-0,72
1,32
-0,52
Interest and investment income
-
-
70,70 მლნ.
-
Interest expense
-824,20 მლნ.
-892,40 მლნ.
-805,40 მლნ.
-880,80 მლნ.
Net interest expenses
-824,20 მლნ.
-892,40 მლნ.
-734,70 მლნ.
-880,80 მლნ.
Depreciation and amortization charges
2,03 მლრდ.
2,13 მლრდ.
2,18 მლრდ.
2,24 მლრდ.
EBITDA
1,45 მლრდ.
1,68 მლრდ.
4,32 მლრდ.
1,57 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები